421 related articles for article (PubMed ID: 23992279)
21. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
22. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
[TBL] [Abstract][Full Text] [Related]
23. [Medical therapy in revascularized coronary artery disease patients].
Liu XH; DU X; Kang JP; Lü Q; Zhang Q; Lü SZ; Chen F; Ma CS
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):236-9. PubMed ID: 18361833
[TBL] [Abstract][Full Text] [Related]
24. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
Sedlis SP; Jurkovitz CT; Hartigan PM; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; O'Rourke RA; Boden WE; Weintraub WS;
Am J Cardiol; 2009 Dec; 104(12):1647-53. PubMed ID: 19962469
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-Converting Enzyme Inhibitor-based Versus Angiotensin Receptor Blocker-based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study.
Park S; Kim YG; Ann SH; Park HW; Suh J; Roh JH; Cho YR; Han S; Park GM
J Cardiovasc Pharmacol; 2021 Jan; 77(1):61-68. PubMed ID: 33165139
[TBL] [Abstract][Full Text] [Related]
26. Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
Kawashima H; Serruys PW; Ono M; Hara H; O'Leary N; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Sharif F; McEvoy JW; Onuma Y;
J Am Coll Cardiol; 2021 Jul; 78(1):27-38. PubMed ID: 34210411
[TBL] [Abstract][Full Text] [Related]
27. [The application status of optimal medical therapy after percutaneous coronary intervention and its influence on prognosis].
Zhang J; Jing R; Liu JJ; Di CY; Lu YJ; Gao P; Wang YJ; Yang RF; Lin WH
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1064-1070. PubMed ID: 33878833
[No Abstract] [Full Text] [Related]
28. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
[TBL] [Abstract][Full Text] [Related]
29. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
30. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry).
Bandeali SJ; Gosch K; Alam M; Kayani WT; Jneid H; Fiocchi F; Wilson JM; Chan PS; Deswal A; Maddox TM; Virani SS
Am J Cardiol; 2015 Apr; 115(8):1013-8. PubMed ID: 25721483
[TBL] [Abstract][Full Text] [Related]
31. Benefit of post PCI medical checklist to improve adhering with best practice guidelines in the patients with coronary artery disease undergoing percutaneous coronary intervention (PCI).
Phed-on U; Naowapanich S; Poolsawat U; Nimmannit A; Wongpraparut N
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S1-10. PubMed ID: 21728269
[TBL] [Abstract][Full Text] [Related]
32. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
[TBL] [Abstract][Full Text] [Related]
33. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
[TBL] [Abstract][Full Text] [Related]
34. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.
Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S
Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920
[TBL] [Abstract][Full Text] [Related]
35. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
36. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
37. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
39. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
[TBL] [Abstract][Full Text] [Related]
40. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]